NCT02739360 2020-03-04
Roll Over Study to Provide Idelalisib to Participants Previously Treated With the Investigational PI3Kδ Inhibitor, GS-9820
Gilead Sciences
Phase 4 Terminated
Clinical Trials
4 trialsNCT01435447 2018-11-02
Fludarabine/Busulfan and Cyclophosphamide Conditioning for Adult Lymphoid Malignancies
Shanghai Jiao Tong University School of Medicine
Phase 2 Completed
NCT01013818 2013-08-02
A Study of HGS1029 in Subjects With Relapsed or Refractory Lymphoid Malignancies
Human Genome Sciences Inc.
Phase 1 Terminated
NCT00508807 2012-07-30
RTA 402 in Advanced Solid Tumors or Lymphoid Malignancies
M.D. Anderson Cancer Center
Phase 1 Completed